• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Repligen Corporation - Common Stock (NQ:RGEN)

    162.59 -1.27 (-0.77%)
    Streaming Delayed Price Updated: 1:41 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 280,634
    Open 163.53
    Bid (Size) 162.39 (100)
    Ask (Size) 162.83 (100)
    Prev. Close 163.86
    Today's Range 162.21 - 167.50
    52wk Range 102.97 - 182.52
    Shares Outstanding 55,679,964
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    1 Volatile Stock to Target This Week and 2 We Turn Down
    Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
    Via StockStory
    News headline image
    Why Repligen (RGEN) Stock Is Trading Up Today
    Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 5.7% in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate... 
    Via StockStory
    Topics Artificial Intelligence Economy Stocks

    Performance

    YTD
    N/A
    N/A
    1 Month
    -1.5%
    -1.5%
    3 Month
    +12.0%
    +12.0%
    6 Month
    +27.6%
    +27.6%
    1 Year
    +13.7%
    +13.7%

    More News

    Read More
    News headline image
    Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    Earnings Scheduled For October 28, 2025 ↗
    Via Benzinga
    News headline image
    3 Cash-Producing Stocks We Approach with Caution
    Via StockStory
    News headline image
    Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)
    Via StockStory
    News headline image
    5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    3 Hyped Up Stocks with Open Questions
    Via StockStory
    News headline image
    RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset
    Via StockStory
    News headline image
    Why Repligen (RGEN) Shares Are Trading Lower Today
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates ↗
    Via Chartmill
    News headline image
    Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates
    Via StockStory
    Topics Earnings
    News headline image
    Repligen Earnings: What To Look For From RGEN
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Inflated Stocks with Questionable Fundamentals
    Via StockStory
    News headline image
    Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions
    Via MarketMinute
    Topics Artificial Intelligence Bonds Credit Cards
    News headline image
    Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    News headline image
    What 8 Analyst Ratings Have To Say About Repligen ↗
    Via Benzinga
    News headline image
    Why Is Repligen (RGEN) Stock Soaring Today
    Via StockStory
    Topics Government
    News headline image
    Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Government
    News headline image
    1 Volatile Stock to Target This Week and 2 Facing Challenges
    Via StockStory
    News headline image
    3 Reasons to Sell RGEN and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks
    News headline image
    Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)
    Via StockStory
    News headline image
    This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
    Via Benzinga
    News headline image
    Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property

    Frequently Asked Questions

    Is Repligen Corporation - Common Stock publicly traded?
    Yes, Repligen Corporation - Common Stock is publicly traded.
    What exchange does Repligen Corporation - Common Stock trade on?
    Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Repligen Corporation - Common Stock?
    The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
    What is the current price of Repligen Corporation - Common Stock?
    The current price of Repligen Corporation - Common Stock is 162.59
    When was Repligen Corporation - Common Stock last traded?
    The last trade of Repligen Corporation - Common Stock was at 01/02/26 01:41 PM ET
    What is the market capitalization of Repligen Corporation - Common Stock?
    The market capitalization of Repligen Corporation - Common Stock is 9.05B
    How many shares of Repligen Corporation - Common Stock are outstanding?
    Repligen Corporation - Common Stock has 9B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.